Compare StocksABBV vs LVS

AbbVie Inc. (ABBV) vs Las Vegas Sands Corp. (LVS): Which Is the Better Buy in 2026?

As of 2026-06-19, ABBV is overvalued at $216, with a DCF intrinsic value of $160 and a margin of safety of -35%. LVS is fairly valued at $49, with an intrinsic value of $49 and a margin of safety of 1%. Of the two, LVS has the wider margin of safety.

ABBV
AbbVie Inc.
$216.49
VS
LVS
Las Vegas Sands Corp.
$48.72

Rewards

ABBV
  • AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Gross margin of 72.0% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
LVS
  • Gross margin of 80.1% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Return on equity has consistently exceeded 20% over 4 years, indicating efficient use of shareholder capital.
  • Share count has been reduced by 12% over the past 4 years through buybacks, increasing each share's claim on earnings.

Risks

ABBV
  • Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • FCF yield of 5.4% suggests reasonable valuation assuming continued moderate growth.
  • Trailing P/E of 105.6x is 69% above the historical average of 62.3x — the stock trades at a premium to its own history.
LVS
  • FCF yield of 5.0% suggests reasonable valuation assuming continued moderate growth.
  • High leverage (7.74x net debt/equity) combined with thin interest coverage (-1.0x) poses financial risk.
  • 18 insider sales with no purchases over the past 12 months — a persistent pattern of insider selling.

Key Valuation Metrics

Learn more →
ABBV
LVS
Valuation
$20.81B
Free Cash Flow
$1.62B
5.44%
FCF Yield
5.03%
105.60
Trailing P/E
17.98
13.32
Forward P/E
13.26
Quality & Moat
21.89%
ROIC
15.88%
N/A
ROE
90.45%
72.03%
Gross Margin
80.09%
0.61
PEG Ratio
0.99
Balance Sheet Safety
N/A
Net Debt / Equity
7.74
N/A
Interest Coverage
N/A
2.12
Net Debt / EBITDA
2.58
3.11%
Dividend Yield
2.25%
ABBV: 6Ties: 2LVS: 2
ABBVLVS

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

LVS

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
LVS
$2.81
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$2.57B
Δ Market Cap
+$7.20B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
35.3% Overvalued
Price is 35.3% above estimated fair value
Current Price: $216.49
Fair Value: $160.05
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
LVS
1.3% Margin of Safety
Price is 1.3% below estimated fair value
Current Price: $48.72
Fair Value: $49.35
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

What growth rate is the market pricing in at $216?

+17.1%
Market-Implied Owner Earnings Growth
Standard FCF implies +8.7%

The market implies +17.1% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +8.7%, reflecting heavy growth investment.

LVS

What growth rate is the market pricing in at $49?

+9.8%
Market-Implied Owner Earnings Growth
Standard FCF implies +12.1%

The market implies +9.8% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +12.1%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
LVS
38/100
No Moat
70+ Wide · 40-69 Narrow · <40 None

No durable moat detected, though roic consistency shows some competitive positioning. The business lacks consistent evidence of sustainable advantages.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
LVS
-2.17
Possible Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 76.9%Retail & Other 23.0%
No. of Institutional Holders5,106
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
LVS
Insiders 58.5%Institutions 42.2%
No. of Institutional Holders1,083
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
LVS
0
Buys (3M)
0
Buys (12M)
PANT MUKTESH
Director
$1.00M
@ $43.51 · 2025-03-14
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
0
Sells (3M)
5
Sells (12M)
Total value (12M): $21.79M
PURDUE DAVID R.
Officer
$1.22M
@ $233.56 · 2026-03-04
SIATIS PERRY C.
General Counsel
$4.38M
@ $234.39 · 2026-03-02
SIATIS PERRY C.
General Counsel
$5.15M
@ $230.00 · 2026-02-25
SALEKI-GERHARDT AZITA
Chief Operating Officer
$8.41M
@ $198.42 · 2025-08-12
DONOGHOE NICHOLAS
Officer
$2.64M
@ $198.51 · 2025-08-05
STEWART JEFFREY RYAN
Officer
$12.36M
@ $210.08 · 2025-03-31
REENTS SCOTT T.
Chief Financial Officer
$3.75M
@ $212.34 · 2025-03-14
GONZALEZ RICHARD A
Director
$20.26M
@ $205.45 · 2025-03-03
SIATIS PERRY C.
General Counsel
$5.82M
@ $208.69 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$4.47M
@ $210.45 · 2025-03-03
BUCKBEE KEVIN K
Officer
$3.85M
@ $203.41 · 2025-02-26
RICHMOND TIMOTHY J
Officer
$6.07M
@ $202.90 · 2025-02-26
SIATIS PERRY C.
General Counsel
$1.14M
@ $197.90 · 2025-02-20
BUCKBEE KEVIN K
Officer
$310,032
@ $172.24 · 2024-12-16
GONZALEZ RICHARD A
Officer and Director
$12.40M
@ $186.52 · 2024-08-05
GONZALEZ RICHARD A
Officer and Director
$49.50M
@ $175.00 · 2024-07-17
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
LVS
1
Sells (3M)
18
Sells (12M)
Total value (12M): $333.60M
FORMAN CHARLES D
Director
$616,626
@ $54.09 · 2026-04-27
DUMONT PATRICK
Chief Executive Officer
$3.29M
@ $54.75 · 2026-03-17
GOLDSTEIN ROBERT G
Chief Executive Officer
$83.39M
@ $66.71 · 2025-12-17
GOLDSTEIN ROBERT G
Chief Executive Officer
$50.09M
@ $66.79 · 2025-12-15
GOLDSTEIN ROBERT G
Chief Executive Officer
$26.57M
@ $66.42 · 2025-12-11
DUMONT PATRICK
President
$9.22M
@ $67.96 · 2025-12-03
DUMONT PATRICK
President
$15.91M
@ $69.88 · 2025-12-02
HUDSON D. ZACHARY
Officer
$3.75M
@ $70.37 · 2025-12-01
CHAFETZ IRWIN
Director
$2.09M
@ $69.76 · 2025-12-01
GOLDSTEIN ROBERT G
Chief Executive Officer
$7.02M
@ $70.17 · 2025-12-01
HYZAK RANDY A.
Chief Financial Officer
$3.82M
@ $66.45 · 2025-11-25
HUDSON D. ZACHARY
Officer
$6.50M
@ $64.99 · 2025-11-07
GOLDSTEIN ROBERT G
Chief Executive Officer
$25.22M
@ $63.04 · 2025-11-06
GOLDSTEIN ROBERT G
Chief Executive Officer
$23.68M
@ $59.20 · 2025-10-31
GOLDSTEIN ROBERT G
Chief Executive Officer
$53.02M
@ $58.92 · 2025-10-30
GOLDSTEIN ROBERT G
Chief Executive Officer
$17.80M
@ $59.32 · 2025-10-27
FORMAN CHARLES D
Director
$1.08M
@ $54.13 · 2025-09-10
FORMAN CHARLES D
Director
$526,300
@ $52.63 · 2025-08-06
HUDSON D. ZACHARY
Officer
$1.33M
@ $51.40 · 2024-11-27
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😐Neutral(56/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
LVS
FearGreed
😨Fear(34/100)

"Market is pessimistic — investigate whether fears are temporary or structural"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (56)
LVS
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Fear (34)
View ABBV Full AnalysisView LVS Full Analysis

Frequently Asked Questions: ABBV vs LVS

Is AbbVie Inc. or Las Vegas Sands Corp. more undervalued in 2026?

Based on our discounted cash flow model, LVS trades at a 1.3% margin of safety (intrinsic value $49 vs. price $49), compared to ABBV's -35.3% margin of safety (intrinsic $160 vs. $216).

Which stock has a wider economic moat, AbbVie Inc. or Las Vegas Sands Corp.?

ABBV scores 82/100 (Wide moat), while LVS scores 38/100 (None moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is AbbVie Inc. in financial distress?

ABBV's Altman Z-Score of 2.4 places it in the Grey zone, signaling elevated bankruptcy risk. LVS scores 2.7 (Grey zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which company has better free cash flow, AbbVie Inc. or Las Vegas Sands Corp.?

AbbVie Inc. (ABBV) generates a 5.4% free cash flow yield, compared to Las Vegas Sands Corp.'s 5.0%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, AbbVie Inc. or Las Vegas Sands Corp.?

ABBV earns 21.9% ROIC versus LVS's 15.9%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, AbbVie Inc.'s or Las Vegas Sands Corp.'s?

LVS's dividend earns a safety score of 81/100 (Very Safe), compared to ABBV's 39/100 (Unsafe). LVS has raised its dividend for 2 consecutive years.